A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis (Q86173600)
Jump to navigation
Jump to search
scientific article published on 01 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis |
scientific article published on 01 March 2013 |
Statements
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis (English)
Kalpalatha Guntupalli
Nathan Dean
Peter E Morris
Venkata Bandi
Benjamin Margolis
Emanuel Rivers
Mitchell Levy
Robert F Lodato
Preeti M Ismail
Amber Reese
John P Schaumberg
Rajesh Malik
R Phillip Dellinger
TLF LF-0801 Investigator Group